Swedish MPA approves First in Human trial of Ilya Pharma’s first-in-class ILP100 topical wound care therapy
Ilya Pharma developing advanced biologics announced that a first in human trial for its lead candidate ILP100 has been approved by the Swedish Medical Products Agency. ILP100 is based on genetically engineered lactic acid bacteria […]